Trial Profile
Dose-escalation trial of RAD 1901 in healthy postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2020
Price :
$35
*
At a glance
- Drugs Elacestrant (Primary) ; Elacestrant (Primary)
- Indications Breast cancer
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Radius Health Inc.
- 13 Jul 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
- 24 Mar 2009 Status changed from planning to completed; Radius reports that a favorable safety profile was observed in phase I trials.